The only international event dedicated to discussing regulatory, ethical and operational aspects of running clinical trials in Russia

30 November - 1 December 2021

Moscow, Russia, Intercontinental Hotel


Back to sponsors page
Back to sponsors page

Supporting organisations 2021:

Media Partners 2021:

IPHARMA is a contract research organization focusing on conducting clinical trials and the registration of investigational drugs and medical devices in Russia and EAEU. IPHARMA is a member of ChemRar High-Tech Center group of companies and an accredited partner of Skolkovo Innovation Center. Our pipeline consists of over 150 clinical trials in oncology, virology, endocrinology, pulmonology, neurology, transplantology, etc. We provide agile clinical services in both early-phase and registration trials, as well as medical, regulatory, and PV expertise to ensure an optimal timeline for your drug development. IPHARMA is a reliable partner and an ideal platform for the clinical development of new medicinal products and medical devices. According to the information-analytical bulletin issued by the Association of Clinical Trial Organizations (ACTO), IPHARMA topped the list of CROs by the number of local trials and bioequivalence trials conducted in 2020.

Visit our website

FoundationOne®CDx is a qualitative next-generation sequencing based in vitro diagnostic test for advanced cancer patients with solid tumors and is for prescription use only. The test analyzes 324 genes as well as genomic signatures including microsatellite instability (MSI) and tumor mutational burden (TMB) and is a companion diagnostic to identify patients who may benefit from treatment with specific therapies in accordance with the approved therapeutic product labeling. Foundation Medicine is your dedicated partner to support your therapeutic development from discovery through to commercialization. Our innovations include proven comprehensive genomic profiling tests, genomic data solutions, clinical trial solutions, and companion diagnostic development/commercialization.

Visit our website

Established in 1994. The Association comprises 60 international pharmaceutical companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation.

AIPM Mission

To promote economic and legal policies that focus on the development of organized and open pharmaceutical market, improving of medical services quality and expansion of the range of modern medicines for the benefit of Russian people.

Visit our website